[1] LOKUHETTY D, WHITE VA, et al.WHO Classification of Tumors Digestive System Tumors(5th Ed)[M] . Lyon, France: IARE Press, 2019:485-487. [2] FLETCHER CD, BRIDGE JA, HOGENDOOM PC, et al.Who Classification of Tumors of soft Tissue and Bone(4th. Ed)[M]. Lyon, France: IARE Press, 2013:62-65. [3] 徐缓, 王欢, 张秀辉, 等. 肝脏上皮样血管平滑肌脂肪瘤25例临床病理分析[J]. 中华病理学杂志, 2014, 43(10):685-689. [4] 王珏儒, 邱法波, 李振凯, 等. 中国肝血管平滑肌脂肪瘤近23年的流行病学特征及诊治经验[J]. 肝胆胰外科杂志, 2012, 24(3):183-187. [5] 安松林, 王黎明, 荣维淇, 等. 肝血管平滑肌脂肪瘤的临床及病理特征分析[J]. 中华肝胆外科杂志, 2014, 20(7):499-502. [6] MOCH H, HUMPHREY PA, ULBRIGHT TM, et al.Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs(4th. Ed)[M]. Lyon, France: IARE Press, 2016:62-65. [7] 中华医学会泌尿外科学分会. 结节性硬化症相关肾血管平滑肌脂肪瘤诊治专家共识. 中华泌尿外科杂志, 2017, 38(5):321-325. [8] WOO YM, RYU SH, MIN JH, et al.Angiomyolipoma of the Liver without a Fat Component, Mimicking a Hepatocellular Carcinoma[J]. Korean J Gastroenterol, 2018, 71(1):49-53. [9] NGUYEN TT, GORMAN B, SHIELDS D, et al.Malignant Hepatic Angiomyolipoma: Report of a Case and Review of Literature[J]. Am J Surg Pathol, 2008, 32(5):793-798. [10] FOLPE AL, MENTZEL T, LEHR HA, et al.Perivascular Epithelioid Cell Neoplasms of Soft Tissue and Gynecologic Origin[J]. Am J Surg Pathol, 2005, 29(12):1558-1575. [11] HORNICK JL, FLECHER CDM.PEComa: What do we know so far?[J] Histopathology, 2006, 48(1):75-82. [12] HAIGES D, KURZ P, LAAFF H, et al.Malignant PEComa[J]. J Cutan Pathol, 2018, 45(1):84-89. [13] DALLE I, SCIOT R, AERTS R.Malignant angiomyolipoma of the liver: a hitherto unreported variant[J]. Histopathology, 2001, 36(5):443-450. [14] BISSLER JJ, KINGWOOD JC.Renal angiomyolipomata[J]. Kidney Int, 2004, 66(3):924-934. [15] 罗荣奎, 赵婧, 谭云山, 等, 肝脏血管平滑肌脂肪瘤182例临床病理特征及预后分析[J]. 中华病理学杂志, 2016, 45(3):165-169. [16] BONETTI F, MARTIGNONI G, COLATO C, et al.Abdominopelvic Sarcoma of Perivascular Epithelioid Cells. Report of Four Cases in Young Women, One with Tuberous Sclerosis[J]. Mod Pathol, 2001, 14(6):563-568. [17] 蔡燚, 李汉忠, 张玉石. 结节性硬化症相关肾脏血管平滑肌脂肪瘤患者临床表型与基因型的关系[J]. 中华泌尿外科杂志, 2016, 37(12):912-915. [18] JIMBO N, NISHIGAMI T, NOGUCHI M, et al.Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations[J]. Human Pathology, 2017, 61:41-48. [19] HUANG SC, CHUANG HC, CHEN TD, et al.Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2[J]. Histopathology, 2015, 66(5):695-705. [20] 李超, 梁磊, 王明达, 等. 肝血管平滑肌脂肪瘤的诊断及治疗选择(附130例回顾性分析)[J]. 腹部外科杂志, 2019, 32(6):404-407. [21] 毛家玺, 滕飞, 袁航, 等. 409例肝上皮样血管平滑肌脂肪瘤汇总分析[J]. 中华肝胆外科杂志, 2018, 24(10):659-663. [22] KLOMPENHOUWER AJ, VERVER D, JANKI S, et al.Management of hepatic angiomyolipoma: A systematic review[J]. Liver Int, 2017, 37(9):1272-1280. |